ZFHX4 and ovarian serous cystadenocarcinoma: Our team showed that ZFHX4-AS1 was related to survivals in eight tumors, namely, uterine corpus endometrial carcinoma (UCEC), stomach adenocarcinoma (STAD), sarcoma (SARC), ovarian serous cystadenocarcinoma (OV), adrenocortical carcinoma (ACC), kidney chromophobe (KICH), kidney renal clear cell carcinoma (KIRC), and bladder urothelial carcinoma (BLCA).